Search All News
Columbia-led study hold promise for helping people find therapies that work.
Studies indicate that 29% to 46% of patients diagnosed with major depressive disorder show partial or no response to treatments.
This year’s Eric D. Hadar Distinguished Lecturer, Dr. Rajita Sinha, will present “Can We Rescue Stress and Trauma Related Pathophysiology in Addiction to Improve Treatment Outcomes?” on Nov. 16, 2022.
Patients who participate in fewer than two visits early in treatment are at risk for relapse, overdose, and possible death.
- October 12, 2022
Project Engage trains lay community workers to deliver brief, evidence-based interventions for mental illnesses and addictions.
- October 4, 2022
Columbia Psychiatry's Psychodynamic Formulation Collective, has published Psychodynamic Formulation: An Expanded Approach.
Source:Science FridaySeptember 16, 2022
"We need better drugs and new drugs, not just the psychedelics and the ketamine, but new allotted treatments that are more effective," said Dr. David Hellerstein.
Source:The Wall Street JournalSeptember 1, 2022
“There is a very important place for stimulant medication in the treatment of ADHD, and we have to be good guardians to know who is going to be best served by them," said Dr. Frances Levin.
Source:The New York TimesAugust 27, 2022
“When they’re searching for something that makes the patient symptom-free, they create problems that can result in what is politely called pharmaceutical misadventure." Dr. Mark Olfson said.
- July 27, 2022
In this Q & A, Dr. Lauren Hoffman discusses social anxiety disorder, how virtual reality therapy works, and why VR treatment is a promising option for teens and young adults.
Source:The New York TimesJune 15, 2022
“The APA doesn’t really have an official position on the best way to treat the kids,” says Jack Drescher, MD, a clinical professor of psychiatry at Columbia regarding gender-affirming care.
Source:Medical News TodayMay 27, 2022
Adrian Jacques Ambrose, MD, MPH, FAPA, medical director of the Columbia Psychiatry Faculty Practice Organization, discusses the newest research into the neuroscience of anxiety and depression.
- May 17, 2022
At Columbia Cohen Center for Health and Recovery from Tick-borne diseases, Kristen Kendrick takes the time to assess the patient from multiple perspectives.
Source:The New York TimesMay 17, 2022
Chacku Mathai, a project director with OnTrackNY, thinks about whether, if the perfect antipsychotic existed, he would take it. “My experience is so rich,” he said, “I wouldn’t trade it for anything.”